The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What is the optimal timepoint for post-transplant MRD assessment?

During the 2021 TCT Meetings Digital Experience, the AML Hub spoke to Andrés Gómez De León, Universidad Autónoma de Nuevo León, Monterrey, MX. We asked, What is the optimal timepoint for post-transplant MRD assessment?

What is the optimal timepoint for post-transplant MRD assessment?

Gómez De León discusses the association between Day +30 and +100 measurable residual disease (MRD) status and relapse following peripheral blood hematopoietic stem cell transplant (HSCT) in adult patients with high-risk acute leukemia.

 

Share: